-
<![CDATA[How Modern Research Is Transforming Metastatic HER2+ Breast Cancer Care]]>
20 Dec 2025 01:16 GMT
… metastatic breast cancer are living … Taxotere in patients with treatment-naive, metastatic HER2-positive breast cancer … breast cancers, including aggressive triple-negative breast cancers … breast cancer are cured? Typically, we treat metastatic breast cancer …
-
ADC therapies reset treatment standards for HER2-positive and triple-negative breast cancer
12 Dec 2025 06:21 GMT
… results presenting new breast cancer treatment strategies based … ) for triple-negative breast cancer (TNBC) patients who … THP regimen — combining Taxotere (docetaxel), Herceptin (trastuzumab … stated, “HER2-positive breast cancer is inherently aggressive, …
-
Triple Negative Breast Cancer Pipeline Outlook Report 2025: Key 165+ Companies And Breakthrough Therapies Shaping The Future Landscape
13 Aug 2025 00:33 GMT
… Breast Cancer Pipeline Therapies- Nanosomal Docetaxel Lipid Suspension (75 mg/m2), Taxotere … Breast Cancer Companies
Triple Negative Breast Cancer Products
Triple Negative Breast Cancer Unmet Needs
Triple Negative Breast Cancer …
-
This 25-year-old survived breast cancer. Next, menopause.
31 Jul 2025 13:10 GMT
… ? Or ...
Breast cancer. Maybe it's breast cancer. At 24 … She had triple positive breast cancer, meaning her tumor cells … after blood draw.
Cheotherapy (Taxotere and Carboplatin) and hormone … about menopause symptoms after breast cancer can check out …
-
South Korea's Boryung to acquire global rights to Taxotere from Sanofi for €175 M
06 Oct 2025 06:21 GMT
… with Sanofi for breast cancer treatment Taxotere in 19 countries
… cytotoxic anti-cancer drug Taxotere (docetaxel) across global territories … , Boryung will manufacture Taxotere at its Yesan Campus … of Essential Medicines, and Taxotere is the original product …
-
Korea's Boryung looks to stir up new value in Sanofi's legacy chemo Taxotere with $205M rights buy
01 Oct 2025 01:34 GMT
… ’s time-honored chemotherapy Taxotere (docetaxel) in nearly … 16 million), encompasses Sanofi’s Taxotere business in 19 countries, … early stage and metastatic breast cancer as well as metastatic … last year.
Sanofi’s Taxotere revenues rapidly declined from …
-
Triple Negative Breast Cancer Pipeline Appears Robust With 165+ Key Pharma Companies Actively Working In The Therapeutics Segment | Delveinsight
21 May 2025 02:35 GMT
… Breast Cancer Pipeline Therapies- Nanosomal Docetaxel Lipid Suspension (75 mg/m2), Taxotere … Breast Cancer Companies
Triple Negative Breast Cancer Products
Triple Negative Breast Cancer Unmet Needs
Triple Negative Breast Cancer …
-
FDA Accepts Biologics License Application for Pertuzumab Biosimilar to Treat Breast Cancer
10 Feb 2025 21:09 GMT
… Taxotere; Hikma) is approved by the FDA to treat HER2+ metastatic breast cancer … for HER2-positive breast cancer. FDA. News release … -zzxf-her2-positive-breast-cancer#:~:text=On%20June%2029%2C%202020%2C%20the,the%20neoadjuvant%20and%20adjuvant%20therapies …
-
Breast cancer treatment side effect for women of color
27 Dec 2024 22:39 GMT
… said.
She’s also a breast cancer survivor. In 2019, at … said.
She had stage 2 breast cancer. She started chemotherapy, and … of Black women with breast cancer who were undergoing treatment … a commonly used drug called Taxotere or docetaxel, has significantly …
-
Health Spotlight | Black women and breast cancer
27 Dec 2024 03:06 GMT
… Women undergoing chemotherapy for breast cancer often face many side effects … She had stage two breast cancer. She started chemotherapy and … Black women with breast cancer who were undergoing … commonly used drug called Taxotere or Docetaxel, has significantly …